Search
for
Sort by
Research 91–120 of 1000+
- Erythematous cutaneous nodules caused by adulterated cocaine
- Ox40-Cre–mediated deletion of BRD4 reveals an unexpected phenotype of hair follicle stem cells in alopecia
- Alopecia Areata: An Overview of the Disease and its Genetic Basis: Review Article
- The Pathogenesis of Alopecia Areata in Rodent Models
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Single-Nucleus and Bulk RNA Sequencing Reveals the Involvement of Natural Killer and CD8+ T Cells in the Progression of Androgenetic Alopecia
- Multiple eruptive milia in chronic graft versus host disease: A case report
- INTERFERONS IN DERMATOLOGY
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Calreticulin: non‐endoplasmic reticulum functions in physiology and disease
- Ku80 as a Novel Receptor for Thymosin β4 That Mediates Its Intracellular Activity Different from G-actin Sequestering
- TNC+ fibroblasts involve in skin inflammation via neuro-immune and interacting with T cells
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- HuR ablation destabilizes Foxp3 mRNA and impairs regulatory T cell function, contributing to an autoimmune phenotype
- Stem Cell Competition for Niche Occupancy: Emerging Themes and Mechanisms
- Three cases of immune‐mediated adnexal skin disease treated with cyclosporin
- Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
- Regulatory T cells in inflammatory skin disease: from mice to humans
- CUTANEOUS T-CELL LYMPHOMA
- The gut microbiome and Alopecia areata: Implications for early diagnostic biomarkers and novel therapies
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata
- Nail involvement in frontal fibrosing alopecia
- Biological significance of FoxN1 gain-of-function mutations during T and B lymphopoiesis in juvenile mice
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice